Nature, Published online: 22 January 2025; doi:10.1038/s41586-024-08439-0

Mitochondria with mutations in their DNA from cancer cells can be transferred to T cells in the tumour microenvironment, which leads to T cell dysfunction and impaired antitumour immunity.